Transplant Information - October 6, 2008

Improper Transplant Leads To Suspension Of Program

September 27, 2005 - Topics transplant and hospital
St. Vincent Medical Center, one of California's largest organ transplant centers, has suspended its liver program after determining that doctors improperly arranged a liver transplant for a man not among the highest-priority patients.

According to hospital President and Chief Executive Gus Valdespino, the staff then falsified documents to cover up the alleged wrongdoing

read more >>

Scientists Use Mouse Stem Cells To Repair Sheep Hearts

September 16, 2005 - Topics hospital, diabetes, heart disease, men and europe

Hector Duarte Jr. - All Headline News Staff Reporter

Researchers at the National Center for Scientific Research in Montpellier, France and the European Hospital Georges Pompidou in Paris, transplanted mouse cells into nine sheep that had suffered heart attacks

read more >>

Fluorescent Fish Used In Cancer Research

September 1, 2005 - Topics research, flu, cancer, fish and transplant
Fluorescent fish are being used by Taiwanese researchers instead of mice to show the impact of experimental drugs on cancerous tumors.

Wu Jen-leih of Taipei's Academia Sinica headed a team that took a gene that makes jelly fish fluoresce and transplanted it into the livers of zebra fish that were then later implanted with cancer cells for testing, The Associated Press reports

read more >>

Leeches and Maggots Considered For Medical Procedures

August 31, 2005 - Topics hospital, water, medicine, transplant and surgery
The Food and Drug Administration is considering the use of leeches and maggots in more medical procedures.

Lisa Darmo, of Carolina Biological Supply in Burlington, says special leeches for medical use only are imported from England and shipped to hospitals across the country

read more >>

Heart Attack Cure Under Investigation

July 26, 2005 - Topics blood, safety, transplant and study
Scientists at John Hopkins University are studying trials on pigs resulting in 50% to 75% restoration of their damaged hearts by transmitting adult stem cells transplanted from bone marrow.

Now, two patients have signed up for the human trials and are set to begin. According to the report, the study of 48 heart attack patients that will ultimately take part in the phase 1 study, which is designed to test the safety of injecting adult stem cells into their hearts

read more >>





© Copyright 2008 Webmedia Publishing, SA - all rights reserved.     Contact Us  |  Privacy Policy  |  Disclaimer  |  Terms of Use